Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007
Published online before print May 3, 2007, doi: 10.1161/01.RES.0000269042.58594.f6
A more recent version of this article appeared on May 25, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/10/1460    most recent
01.RES.0000269042.58594.f6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keskitalo, S.
Right arrow Articles by Alitalo, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keskitalo, S.
Right arrow Articles by Alitalo, K.
Related Collections
Right arrow Angiogenesis
Right arrow Other Vascular biology

Submitted on December 21, 2006
Revised on March 30, 2007
Accepted on April 25, 2007

Enhanced Capillary Formation Stimulated by a Chimeric Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor-C Silk Domain Fusion Protein

Salla Keskitalo ; Tuomas Tammela ; Johannes Lyytikka ; Terhi Karpanen ; Michael Jeltsch ; Johanna Markkanen ; Seppo Yla-Herttuala ; and Kari Alitalo *

From the Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research (S.K., T.T., J.L., T.K., M.J., K.A.), Biomedicum Helsinki, Haartman Institute and Helsinki University Central Hospital, University of Helsinki; and The A.I. Virtanen Institute and Department of Medicine (J.M., S.Y.-H.), University of Kuopio, Finland.

* To whom correspondence should be addressed. E-mail: Kari.Alitalo{at}helsinki.fi.

Vascular endothelial growth factor (VEGF)-C and VEGF-D require proteolytic cleavage of the carboxy terminal silk-homology domain for activation. To study the functions of the VEGF-C propeptides, we engineered a chimeric growth factor protein, VEGF-CAC, composed of the amino- and carboxy-terminal propeptides of VEGF-C fused to the receptor-activating core domain of VEGF. Like VEGF-C, VEGF-CAC underwent proteolytic cleavage, and like VEGF, it bound to and activated VEGF receptor-1 and VEGF receptor-2, but not the VEGF-C receptor VEGF receptor-3. VEGF-CAC also bound to neuropilins in a heparin-dependent manner. Strikingly, when VEGF-CAC was expressed via an adenovirus vector in the ear skin of immunodeficient mice, it proved to be a more potent inducer of capillary angiogenesis than VEGF. The VEGF-CAC-induced vessels differed greatly from those induced by VEGF, as they formed a very dense and fine network of pericyte and basement membrane-covered capillaries that were functional, as shown by lectin perfusion experiments. VEGF-CAC could prove useful in proangiogenic therapies in patients experiencing tissue ischemia.


Key words: proangiogenic therapy • gene therapy • growth factors




This article has been cited by other articles:


Home page
Circ. Res.Home page
A. Anisimov, A. Alitalo, P. Korpisalo, J. Soronen, S. Kaijalainen, V.-M. Leppanen, M. Jeltsch, S. Yla-Herttuala, and K. Alitalo
Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle
Circ. Res., June 5, 2009; 104(11): 1302 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Simons
Silky, Sticky Chimeras-Designer VEGFs Display Their Wares
Circ. Res., May 25, 2007; 100(10): 1402 - 1404.
[Full Text] [PDF]